Your search returned 18 studies. (Get alerts for new studies):
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
2 Locations available
- A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bor
Conditions: Mantle Cell Lymphoma
26 Locations available
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, Follicular
6 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL) - Chronic Lymphocytic Leukemia (CLL) - Non-Hodgkins Lymphoma (NHL) - Cutaneous T Cell Lymphoma (CTCL) - Adult T Cell Lymphoma (ATL)
1 Location available
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL) - Leukemia, Myeloid, Acute(AML) - Leukemia, Myeloid, Chronic(CML) - Juvenile Myelomonocytic Leukemia (JMML) - Hemoglobinuria, Paroxysmal Nocturnal (PNH) - Hodgkin Lymphoma - Lymphoma, Non-Hodgkin (NHL) - Myelodysplastic S
1 Location available
- Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
Conditions: Lymphoma, Non-Hodgkin
9 Locations available
- Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 kg
Conditions: Non-Hodgkin's Lymphoma
9 Locations available
- Ofatumumab and Bortezomib in Subjects With Relapsed CD20+ NHL
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Grade 3 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma
1 Location available
- NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma
Conditions: Lymphoblastic Lymphoma
1 Location available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
- Oral Clofarabine for Relapsed/Refractory Indolent B-cell NHL and Mantle Cell Lymphoma
Conditions: Follicular Lymphoma - Marginal Zone Lymphoma - Mantle Cell Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytic Lymphoma - Low Grade B-cell Lymphoma, Not Otherwise Specified
2 Locations available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
9 Locations available
- Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
Conditions: Non-Hodgkin's Lymphoma
4 Locations available
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL - Lymphoma, Non-Hodgkin - Lymphoma, B-Cell - Lymphoma, Follicular - Lymphoma, Intermediate-Grade - Lymphoma, Large-Cell - Lymphoma, Low-Grade - Lymphoma, Mixed-Cell - Lymphoma, Small-Cell - Leukemia, Lymphocytic, Chronic - Leukemia, B-Cell, Chronic -
4 Locations available
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
1 Location available
- Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL
Conditions: Non Hodgkin's Lymphoma - NHL - Aggressive NHL
3 Locations available
|